Peng-cheng He

发表

Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein

Jing Zhao, F. Liu, Jing Zhao, 2014, PloS one.

Expression of Concern: Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein

T. Hofmann, Feng Liu, J. Zhao, 2014, PloS one.

Tetra-arsenic tetra-sulfide (As4S4) promotes apoptosis in retinoid acid -resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein

Jing Zhao, F. Liu, Jing Zhao, 2014, Tumor Biology.

Therapeutic experience of vincristine/cyclophosphamide/melphalan or mitoxantrone/prednisone combination therapy plus thalidomide as first‐line induction therapy for newly diagnosed multiple myeloma in a single institution of China

Peng-cheng He, Mei Zhang, Xiaoning Wang, 2017, Asia-Pacific journal of clinical oncology.

Role of cofilin-1 in arsenic trioxide-induced apoptosis of NB4-R1 cells

J. Zhao, Xiaoyan Zheng, Peng-cheng He, 2020, Molecular medicine reports.

Tetra-arsenic tetra-sulfide induces cell cycle arrest and apoptosis in retinoic acid-resistant acute promyelocytic leukemia cells.

Yuan Wang, Yanfeng Liu, Peng-cheng He, 2015, Biomedical reports.

A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma

S. Grupp, Bryan Zimdahl, M. Luo, 2022, Journal of Cancer Research and Clinical Oncology.

Construction of SET overexpression vector and its effects on the proliferation and apoptosis of 293T cells.

Yuan Wang, Yanfeng Liu, Peng-cheng He, 2016, Molecular medicine reports.

The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts

Jianda Hu, Depei Wu, Ligen Liu, 2022, Journal of clinical apheresis.

Prohibitin promotes apoptosis of promyelocytic leukemia induced by arsenic sulfide.

Jing Zhao, Yuan Wang, Yanfeng Liu, 2015, International journal of oncology.

De Novo design of a humanized antiCD33 antibody-oridonin conjugate for acute myeloid leukemia therapy.

Peng-hui Zhang, Fan Niu, Mengyao Zhang, 2022, Biochemical and biophysical research communications.

Kill Two Birds with One Stone: A Multifunctional Dual‐Targeting Protein Drug to Overcome Imatinib Resistance in Philadelphia Chromosome‐Positive Leukemia

Fan Niu, Peng-cheng He, Bohan Ma, 2022, Advanced science.

ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation

Li Lei, Li Lei, Rong Fan, 2020, Stem Cell Research & Therapy.